<?xml version="1.0" encoding="utf-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:types="http://xbrl.frc.org.uk/general/2019-01-01/types" xmlns:uk-ref="http://xbrl.frc.org.uk/general/2019-01-01/ref" xmlns:common="http://xbrl.frc.org.uk/general/2019-01-01/common" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:curr="http://xbrl.frc.org.uk/cd/2019-01-01/currencies" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:countries="http://xbrl.frc.org.uk/cd/2019-01-01/countries" xmlns:lang="http://xbrl.frc.org.uk/cd/2019-01-01/languages" xmlns:bus="http://xbrl.frc.org.uk/cd/2019-01-01/business" xmlns:accrep="http://xbrl.frc.org.uk/reports/2019-01-01/accrep" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:aurep="http://xbrl.frc.org.uk/reports/2019-01-01/aurep" xmlns:Q1="http://xbrl.org/2005/xbrldt" xmlns:direp="http://xbrl.frc.org.uk/reports/2019-01-01/direp" xmlns:core="http://xbrl.frc.org.uk/fr/2019-01-01/core" xmlns:FRS-102="http://xbrl.frc.org.uk/FRS-102/2019-01-01" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2010-04-20" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:fn="http://www.w3.org/2005/xpath-functions" xmlns:xbrldi="http://xbrl.org/2006/xbrldi"><head><meta content="application/xhtml+xml; charset=UTF-8" http-equiv="Content-Type" /><title>FELLVIEW_HEALTHCARE_LTD - Accounts</title><style type="text/css">@page land { size:landscape; }@page port { size:portrait; }.pageFirst { page-break-after:always;  background-color:white;    border-top:1px solid black;  border-bottom:1px solid black;    border-left:1px solid black;    border-right:1px solid black;   } .portraitPage {    page:port;  width:21cm; height:29.7cm; page-break-after:always; background-color:white; border-top:1px solid black; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; position:relative; } .landscapePage {  page:land;  width:29.7cm; height:21cm; page-break-after:always; background-color:white; border-top:1px solid black; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; position:relative; } a.tooltip {color:black;text-decoration:none}a.tooltip span{display:none}a.tooltip:hover span{display:inline;position:absolute;z-index:5002;background:#ffffff}a.anchor {color:blue;}a.tooltipRTF {color:black;text-decoration:none;display:none}span:hover a.tooltipRTF {display:block;position:absolute;background:#ffffff}span.tooltipRTFtext {position:absolute;left:10;width:200;border:1pt solid black;text-align:left;font-weight:normal;z-index:5002;bottom:20;font-family:Arial;font-size:9;background-color:#FFFFCC; }.c,.crn,.cjn,.cln,.ccn,.crb,.cjb,.clb,.ccb,.crni,.cjni,.clni,.ccni,.crbi,.cjbi,.clbi,.ccbi{position:absolute;word-wrap:break-word}.crn,.cjn,.cln,.ccn,.crni,.cjni,.clni,.ccni{font-weight:normal}.crb,.clb,.cjb,.ccb,.crbi,.cjbi,.clbi,.ccbi{font-weight:bold}.crni,.cjni,.clni,.ccni,.crbi,.cjbi,.clbi,.ccbi{font-style:italic}.crn,.crb,.crni,.crbi{text-align:right}.cln,.clb,.clni,.clbi{text-align:left}.ccn,.ccb,.ccni,.ccbi{text-align:center}.cjn,.cjb,.cjni,.cjbi{text-align:justify}.fn0{font-size:0px}.fn1{font-size:11.7px;font-family:Calibri}.fn2{font-size:10.7px;font-family:Arial}.fn3{font-size:21.3px;font-family:Arial}.fn4{font-size:13.9px;font-family:Arial}.fn5{font-size:12.8px;font-family:Arial}.fn6{font-size:6.4px;font-family:Arial}.fn7{font-size:9.6px;font-family:Arial}.fn8{font-size:0px;font-family:Arial}.fn9{font-size:9.6px;font-family:Courier New}.sln{border-top:1px solid black}.dln{border-top:4px double black}.u{text-decoration:underline}ul,li{ margin-top:0px;margin-bottom:0px;margin-right:0px;margin-left:8px;   padding-top:0px;padding-bottom:0px;padding-right:0px;padding-left:8px;} .img_0_0{width:248px;height:64px;position:absolute;background-repeat:no-repeat;background-image:url('data:image/png;base64,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')}</style></head><body xml:lang="en" style="background-color:white"><div class="pageFirst" style="height:727pt;width:516pt;"><div class="cln fn1 img_0_0" style="top:646.35pt;left:291.19pt;width:186.26pt;"></div><div class="clb fn2" style="top:31.08pt;left:46.61pt;width:423.77pt;"></div><div class="crb fn2" style="top:52.66pt;left:43.61pt;width:420.55pt;"><ix:nonNumeric contextRef="C" name="bus:CountryFormationOrIncorporation"></ix:nonNumeric>Company Registration No. <ix:nonNumeric contextRef="C" name="bus:UKCompaniesHouseRegisteredNumber">06625215</ix:nonNumeric> (England and Wales)</div><div class="ccb fn3" style="top:164.81pt;left:46.61pt;width:420.55pt;"><ix:nonNumeric contextRef="C" name="bus:EntityCurrentLegalOrRegisteredName">FELLVIEW HEALTHCARE LTD</ix:nonNumeric></div><div class="ccb fn4" style="top:197.2pt;left:46.61pt;width:420.55pt;"><ix:nonNumeric contextRef="C" name="bus:ReportTitle">UNAUDITED FINANCIAL STATEMENTS</ix:nonNumeric></div><div class="ccb fn4" style="top:222.37pt;left:46.61pt;width:420.55pt;">FOR THE YEAR ENDED 30 JUNE 2019</div><div class="ccb fn4" style="top:247.66pt;left:46.61pt;width:420.55pt;">PAGES FOR FILING WITH REGISTRAR</div></div><div class="portraitPage" style="height:727pt;width:516pt;"><div class="clb fn2" style="top:31.08pt;left:46.61pt;width:423.77pt;"></div><div class="clb fn5" style="top:41pt;left:46.61pt;width:423.77pt;"><ix:nonNumeric contextRef="C" name="bus:EntityCurrentLegalOrRegisteredName">FELLVIEW HEALTHCARE LTD</ix:nonNumeric></div><div class="clb fn5" style="top:52.91pt;left:46.61pt;width:423.77pt;"></div><div class="clb fn2" style="top:64.83pt;left:46.61pt;width:423.77pt;">CONTENTS</div><div class="cln fn6" style="top:74.75pt;left:46.61pt;width:420.77pt;"></div><div class="clb fn2" style="top:80.71pt;left:46.61pt;width:423.77pt;"></div><div class="cln fn0 sln" style="top:90.64pt;left:46.61pt;width:420.77pt;"></div><div class="cln fn0 sln" style="top:695.49pt;left:46.61pt;width:420.77pt;"></div><div class="clb fn2" style="top:115.46pt;left:409.6pt;width:60.79pt;">Page</div><div class="cln fn2" style="top:149.12pt;left:46.61pt;width:362.98pt;">Balance sheet</div><div class="cln fn2" style="top:149.12pt;left:409.6pt;width:57.79pt;">2 - 3</div><div class="cln fn2" style="top:194.01pt;left:46.61pt;width:362.98pt;">Notes to the financial statements</div><div class="cln fn2" style="top:194.01pt;left:409.6pt;width:57.79pt;">4 - 9</div></div><div class="portraitPage" style="height:727pt;width:516pt;"><div class="clb fn2" style="top:31.08pt;left:46.61pt;width:423.77pt;"></div><div class="clb fn5" style="top:41pt;left:46.61pt;width:423.77pt;"><ix:nonNumeric contextRef="C" name="bus:EntityCurrentLegalOrRegisteredName">FELLVIEW HEALTHCARE LTD</ix:nonNumeric></div><div class="clb fn5" style="top:52.91pt;left:46.61pt;width:423.77pt;"></div><div class="clb fn2" style="top:64.83pt;left:46.61pt;width:423.77pt;">CHARTERED ACCOUNTANTS' REPORT TO THE BOARD OF DIRECTORS ON THE PREPARATION OF THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OF FELLVIEW HEALTHCARE LTD FOR THE YEAR ENDED 30 JUNE 2019</div><div class="cln fn6" style="top:94.61pt;left:46.61pt;width:420.77pt;"></div><div class="cln fn0 sln" style="top:100.56pt;left:46.61pt;width:420.77pt;"></div><div class="cln fn0 sln" style="top:695.49pt;left:46.61pt;width:420.77pt;"></div><div class="ccn fn7" style="top:701.96pt;left:46.61pt;width:420.77pt;">- 1 -</div><div class="cln" style="top:114pt;left:47pt;width:419pt;text-align:justify;font-family:Arial;font-size:8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn2">In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Fellview Healthcare Ltd for the year ended 30 June 2019 set out on pages  to 9 from the company’s accounting records and from information and explanations you have given us.</span></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn2">&#160;</span></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn2">As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at http://www.icaew.com/en/members/regulations-standards-and-guidance</span><span class="fn2">.</span></p></div><div class="cln" style="top:196pt;left:47pt;width:419pt;text-align:justify;font-family:Arial;font-size:8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="accrep:AccountantsReportOnFinancialStatements" continuedAt="C_NX_0"><span class="fn2">This report is made solely to the Board of Directors of Fellview Healthcare Ltd, as a body, in accordance with the terms of our engagement letter dated 12 January 2018. Our work has been undertaken solely to prepare for your approval the financial statements of Fellview Healthcare Ltd</span></ix:nonNumeric><span class="fn2"> </span><ix:continuation id="C_NX_0" continuedAt="C_NX_1"><span class="fn2">and state those matters that we have agreed to state to the Board of Directors of Fellview Healthcare Ltd, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Fellview Healthcare Ltd and its Board of Directors as a body, for</span></ix:continuation><span class="fn2"> </span><ix:continuation id="C_NX_1"><span class="fn2">our work or for this report.</span></ix:continuation></p></div><div class="cln" style="top:277pt;left:47pt;width:419pt;text-align:justify;font-family:Arial;font-size:8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn2">It is your duty to ensure that Fellview Healthcare Ltd has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets,</span><span class="fn2"> </span><span class="fn2">liabilities, financial position and profit</span><span class="fn2"> </span><span class="fn2">of Fellview Healthcare Ltd. You consider that Fellview Healthcare Ltd is exempt from the statutory audit</span><span class="fn2"> </span><span class="fn2">requirement for the year.</span></p></div><div class="cln" style="top:329pt;left:47pt;width:419pt;text-align:justify;font-family:Arial;font-size:8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn2">We have not been instructed to carry out an audit or a review of the financial statements of Fellview Healthcare Ltd. For this reason, we have not verified the accuracy or completeness of the</span><span class="fn2"> </span><span class="fn2">accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.</span></p></div><div class="clb fn2" style="top:425.79pt;left:46.61pt;width:421.87pt;">MHA Moore and Smalley</div><div class="clb fn2" style="top:437.01pt;left:46.61pt;width:421.87pt;">Chartered Accountants</div><div class="cln fn2" style="top:470.68pt;left:46.61pt;width:418.87pt;">Fylde House</div><div class="cln fn2" style="top:481.9pt;left:46.61pt;width:418.87pt;">Skyways Commercial Campus</div><div class="cln fn2" style="top:493.12pt;left:46.61pt;width:418.87pt;">Amy Johnson Way</div><div class="cln fn2" style="top:504.35pt;left:46.61pt;width:418.87pt;">Blackpool</div><div class="cln fn2" style="top:515.57pt;left:46.61pt;width:261pt;">FY4 3RS</div><div class="cln fn2" style="top:538.01pt;left:46.61pt;width:261pt;">31 March 2020</div></div><div class="portraitPage" style="height:727pt;width:516pt;"><div class="clb fn2" style="top:31.08pt;left:46.61pt;width:423.77pt;"></div><div class="clb fn5" style="top:41pt;left:46.61pt;width:423.77pt;"><ix:nonNumeric contextRef="C" name="bus:EntityCurrentLegalOrRegisteredName">FELLVIEW HEALTHCARE LTD</ix:nonNumeric></div><div class="clb fn5" style="top:52.91pt;left:46.61pt;width:423.77pt;"></div><div class="clb fn2" style="top:64.83pt;left:46.61pt;width:423.77pt;">BALANCE SHEET </div><div class="cln fn6" style="top:74.75pt;left:46.61pt;width:420.77pt;"></div><div class="clb fn2" style="top:80.71pt;left:46.61pt;width:423.77pt;"><div style="display:inline">AS AT 30 JUNE 2019<div style="display:none"><ix:nonNumeric contextRef="B" format="ixt:datelonguk" name="bus:BalanceSheetDate">30 June 2019</ix:nonNumeric></div></div></div><div class="clb fn2" style="top:90.64pt;left:46.61pt;width:423.77pt;"></div><div class="cln fn0 sln" style="top:100.56pt;left:46.61pt;width:420.77pt;"></div><div class="cln fn0 sln" style="top:695.49pt;left:46.61pt;width:420.77pt;"></div><div class="ccn fn7" style="top:701.96pt;left:46.61pt;width:420.77pt;">- 2 -</div><div class="clb fn2" style="top:114.16pt;left:296.45pt;width:59.56pt;">2019</div><div class="clb fn2" style="top:114.16pt;left:409.57pt;width:59.55pt;">2018</div><div class="ccb fn2" style="top:125.38pt;left:199.49pt;width:43.39pt;">Notes</div><div class="crb fn2" style="top:125.38pt;left:236.88pt;width:59.56pt;">£</div><div class="crb fn2" style="top:125.38pt;left:293.45pt;width:59.56pt;">£</div><div class="crb fn2" style="top:125.38pt;left:350.01pt;width:59.55pt;">£</div><div class="crb fn2" style="top:125.38pt;left:406.57pt;width:59.55pt;">£</div><div class="cln fn8" style="top:125.38pt;left:466.77pt;width:0.65pt;"></div><div class="clb fn2" style="top:147.83pt;left:46.61pt;width:365.95pt;">Fixed assets</div><div class="cln fn2" style="top:159.05pt;left:46.61pt;width:152.88pt;">Tangible assets</div><div class="ccb fn2" style="top:159.05pt;left:199.49pt;width:43.39pt;">3</div><div class="crn fn2" style="top:159.05pt;left:296.45pt;width:56.56pt;"><ix:nonFraction contextRef="B" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:PropertyPlantEquipment">35,361</ix:nonFraction></div><div class="crn fn2" style="top:159.05pt;left:409.57pt;width:56.55pt;"><ix:nonFraction contextRef="E" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:PropertyPlantEquipment">80,442</ix:nonFraction></div><div class="clb fn2" style="top:181.49pt;left:46.61pt;width:196.27pt;">Current assets</div><div class="cln fn2" style="top:192.71pt;left:46.61pt;width:152.88pt;">Stocks</div><div class="ccb fn2" style="top:192.71pt;left:199.49pt;width:43.39pt;"></div><div class="crn fn2" style="top:192.71pt;left:239.88pt;width:56.56pt;"><ix:nonFraction contextRef="B" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:TotalInventories">32,231</ix:nonFraction></div><div class="crn fn2" style="top:192.71pt;left:353.01pt;width:56.55pt;"><ix:nonFraction contextRef="E" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:TotalInventories">27,401</ix:nonFraction></div><div class="cln fn2" style="top:203.94pt;left:46.61pt;width:152.88pt;">Debtors</div><div class="ccb fn2" style="top:203.94pt;left:199.49pt;width:43.39pt;">4</div><div class="crn fn2" style="top:203.94pt;left:239.88pt;width:56.56pt;"><ix:nonFraction contextRef="B" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:Debtors">210,827</ix:nonFraction></div><div class="crn fn2" style="top:203.94pt;left:353.01pt;width:56.55pt;"><ix:nonFraction contextRef="E" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:Debtors">315,025</ix:nonFraction></div><div class="cln fn2" style="top:215.16pt;left:46.61pt;width:152.88pt;">Cash at bank and in hand</div><div class="crn fn2" style="top:215.16pt;left:239.88pt;width:56.56pt;"><ix:nonFraction contextRef="B" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:CashBankOnHand">837,429</ix:nonFraction></div><div class="crn fn2" style="top:215.16pt;left:353.01pt;width:56.55pt;"><ix:nonFraction contextRef="E" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:CashBankOnHand">517,458</ix:nonFraction></div><div class="cln fn0 sln" style="top:231.35pt;left:258.06pt;width:38.39pt;"></div><div class="cln fn0 sln" style="top:231.35pt;left:371.18pt;width:38.39pt;"></div><div class="crn fn2" style="top:237.61pt;left:239.88pt;width:56.56pt;"><ix:nonFraction contextRef="B" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:CurrentAssets">1,080,487</ix:nonFraction></div><div class="crn fn2" style="top:237.61pt;left:353.01pt;width:56.55pt;"><ix:nonFraction contextRef="E" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:CurrentAssets">859,884</ix:nonFraction></div><div class="clb fn2" style="top:248.83pt;left:46.61pt;width:155.88pt;">Creditors: amounts falling due within one year</div><div class="ccb fn2" style="top:258.75pt;left:199.49pt;width:43.39pt;">5</div><div class="crn fn2" style="top:258.75pt;left:242.76pt;width:56.56pt;">(<ix:nonFraction contextRef="B_LR_MQ" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:Creditors">332,532</ix:nonFraction>)</div><div class="crn fn2" style="top:258.75pt;left:355.88pt;width:56.55pt;">(<ix:nonFraction contextRef="E_LR_MQ" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:Creditors">324,915</ix:nonFraction>)</div><div class="cln fn0 sln" style="top:274.94pt;left:258.06pt;width:38.39pt;"></div><div class="cln fn0 sln" style="top:274.94pt;left:371.18pt;width:38.39pt;"></div><div class="clb fn2" style="top:281.2pt;left:46.61pt;width:252.84pt;">Net current assets</div><div class="crn fn2" style="top:281.2pt;left:296.45pt;width:56.56pt;"><ix:nonFraction contextRef="B" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:NetCurrentAssetsLiabilities">747,955</ix:nonFraction></div><div class="crn fn2" style="top:281.2pt;left:409.57pt;width:56.55pt;"><ix:nonFraction contextRef="E" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:NetCurrentAssetsLiabilities">534,969</ix:nonFraction></div><div class="cln fn0 sln" style="top:297.38pt;left:314.62pt;width:38.39pt;"></div><div class="cln fn0 sln" style="top:297.38pt;left:427.74pt;width:38.39pt;"></div><div class="clb fn2" style="top:303.64pt;left:46.61pt;width:196.27pt;">Total assets less current liabilities</div><div class="crn fn2" style="top:303.64pt;left:296.45pt;width:56.56pt;"><ix:nonFraction contextRef="B" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:TotalAssetsLessCurrentLiabilities">783,316</ix:nonFraction></div><div class="crn fn2" style="top:303.64pt;left:409.57pt;width:56.55pt;"><ix:nonFraction contextRef="E" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:TotalAssetsLessCurrentLiabilities">615,411</ix:nonFraction></div><div class="clb fn2" style="top:326.08pt;left:46.61pt;width:155.88pt;">Creditors: amounts falling due after more than one year</div><div class="ccb fn2" style="top:336.02pt;left:199.49pt;width:43.39pt;">6</div><div class="crn fn2" style="top:336.02pt;left:296.45pt;width:56.56pt;">-</div><div class="crn fn2" style="top:336.02pt;left:412.44pt;width:56.55pt;">(<ix:nonFraction contextRef="E_LR_MR" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:Creditors">50,000</ix:nonFraction>)</div><div class="clb fn2" style="top:358.45pt;left:46.61pt;width:155.88pt;">Provisions for liabilities</div><div class="ccb fn2" style="top:358.45pt;left:199.49pt;width:43.39pt;"></div><div class="crn fn2" style="top:358.45pt;left:299.33pt;width:56.56pt;">(<ix:nonFraction contextRef="B" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:ProvisionsForLiabilitiesBalanceSheetSubtotal">6,556</ix:nonFraction>)</div><div class="crn fn2" style="top:358.45pt;left:412.44pt;width:56.55pt;">(<ix:nonFraction contextRef="E" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:ProvisionsForLiabilitiesBalanceSheetSubtotal">8,107</ix:nonFraction>)</div><div class="clb fn2" style="top:380.9pt;left:46.61pt;width:155.88pt;">Accruals and deferred income</div><div class="ccb fn2" style="top:380.9pt;left:199.49pt;width:43.39pt;"></div><div class="crn fn2" style="top:380.9pt;left:299.33pt;width:56.56pt;">(<ix:nonFraction contextRef="B" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:AccruedLiabilitiesNotExpressedWithinCreditorsSubtotal">62,801</ix:nonFraction>)</div><div class="crn fn2" style="top:380.9pt;left:412.44pt;width:56.55pt;">(<ix:nonFraction contextRef="E" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:AccruedLiabilitiesNotExpressedWithinCreditorsSubtotal">104,664</ix:nonFraction>)</div><div class="cln fn0 sln" style="top:397.09pt;left:314.62pt;width:38.39pt;"></div><div class="cln fn0 sln" style="top:397.09pt;left:427.74pt;width:38.39pt;"></div><div class="clb fn2" style="top:403.35pt;left:46.61pt;width:196.27pt;">Net assets</div><div class="crn fn2" style="top:403.35pt;left:296.45pt;width:56.56pt;"><ix:nonFraction contextRef="B" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:NetAssetsLiabilities">713,959</ix:nonFraction></div><div class="crn fn2" style="top:403.35pt;left:409.57pt;width:56.55pt;"><ix:nonFraction contextRef="E" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:NetAssetsLiabilities">452,640</ix:nonFraction></div><div class="cln fn0 dln" style="top:419.53pt;left:314.62pt;width:38.39pt;"></div><div class="cln fn0 dln" style="top:419.53pt;left:427.74pt;width:38.39pt;"></div><div class="clb fn2" style="top:437.01pt;left:46.61pt;width:155.88pt;">Capital and reserves</div><div class="cln fn2" style="top:448.23pt;left:46.61pt;width:152.88pt;">Called up share capital</div><div class="ccb fn2" style="top:448.23pt;left:199.49pt;width:43.39pt;">7</div><div class="crn fn2" style="top:448.23pt;left:296.45pt;width:56.56pt;"><ix:nonFraction contextRef="B_MS_MT" decimals="0" scale="0" unitRef="GBP" name="core:Equity">4</ix:nonFraction></div><div class="crn fn2" style="top:448.23pt;left:409.57pt;width:56.55pt;"><ix:nonFraction contextRef="E_MS_MT" decimals="0" scale="0" unitRef="GBP" name="core:Equity">4</ix:nonFraction></div><div class="cln fn2" style="top:459.45pt;left:46.61pt;width:152.88pt;">Profit and loss reserves</div><div class="ccb fn2" style="top:459.45pt;left:199.49pt;width:43.39pt;"></div><div class="crn fn2" style="top:459.45pt;left:296.45pt;width:56.56pt;"><ix:nonFraction contextRef="B_MS_MU" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:Equity">713,955</ix:nonFraction></div><div class="crn fn2" style="top:459.45pt;left:409.57pt;width:56.55pt;"><ix:nonFraction contextRef="E_MS_MU" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:Equity">452,636</ix:nonFraction></div><div class="cln fn0 sln" style="top:475.64pt;left:314.62pt;width:38.39pt;"></div><div class="cln fn0 sln" style="top:475.64pt;left:427.74pt;width:38.39pt;"></div><div class="clb fn2" style="top:481.9pt;left:46.61pt;width:196.27pt;">Total equity</div><div class="crn fn2" style="top:481.9pt;left:296.45pt;width:56.56pt;"><ix:nonFraction contextRef="B" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:Equity">713,959</ix:nonFraction></div><div class="crn fn2" style="top:481.9pt;left:409.57pt;width:56.55pt;"><ix:nonFraction contextRef="E" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:Equity">452,640</ix:nonFraction></div><div class="cln fn0 dln" style="top:498.09pt;left:314.62pt;width:38.39pt;"></div><div class="cln fn0 dln" style="top:498.09pt;left:427.74pt;width:38.39pt;"></div><div class="cln" style="top:516pt;left:47pt;width:420pt;text-align:justify;font-family:Arial;font-size:8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="direp:EntityHasTakenExemptionUnderCompaniesActInNotPublishingItsOwnProfitLossAccountTruefalse"><span class="fn2"><ix:exclude>The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.</ix:exclude><span style="display:none">true</span></span></ix:nonNumeric></p></div><div class="cln" style="top:548pt;left:47pt;width:420pt;text-align:justify;font-family:Arial;font-size:8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="direp:StatementThatCompanyEntitledToExemptionFromAuditUnderSection477CompaniesAct2006RelatingToSmallCompanies"><span class="fn2">For the financial year ended 30 June 2019 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.</span></ix:nonNumeric></p></div><div class="cln" style="top:580pt;left:47pt;width:420pt;text-align:justify;font-family:Arial;font-size:8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="direp:StatementThatDirectorsAcknowledgeTheirResponsibilitiesUnderCompaniesAct"><span class="fn2">The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.</span></ix:nonNumeric></p></div><div class="cln" style="top:612pt;left:47pt;width:420pt;text-align:justify;font-family:Arial;font-size:8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="direp:StatementThatMembersHaveNotRequiredCompanyToObtainAnAudit" continuedAt="C_NY_0"><span class="fn2">T</span></ix:nonNumeric><span class="fn2"></span><ix:continuation id="C_NY_0" continuedAt="C_NY_1"><span class="fn2">he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476</span></ix:continuation><span class="fn2"></span><ix:continuation id="C_NY_1"><span class="fn2">.</span></ix:continuation></p></div><div class="cln" style="top:644pt;left:47pt;width:420pt;text-align:justify;font-family:Arial;font-size:8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="direp:StatementThatAccountsHaveBeenPreparedInAccordanceWithProvisionsSmallCompaniesRegime"><span class="fn2">These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.</span></ix:nonNumeric></p></div></div><div class="portraitPage" style="height:727pt;width:516pt;"><div class="clb fn2" style="top:31.08pt;left:46.61pt;width:423.77pt;"></div><div class="clb fn5" style="top:41pt;left:46.61pt;width:423.77pt;"><ix:nonNumeric contextRef="C" name="bus:EntityCurrentLegalOrRegisteredName">FELLVIEW HEALTHCARE LTD</ix:nonNumeric></div><div class="clb fn5" style="top:52.91pt;left:46.61pt;width:423.77pt;"></div><div class="clb fn2" style="top:64.83pt;left:46.61pt;width:423.77pt;">BALANCE SHEET (CONTINUED)</div><div class="cln fn6" style="top:74.75pt;left:46.61pt;width:420.77pt;"></div><div class="clb fn2" style="top:80.71pt;left:46.61pt;width:423.77pt;"><div style="display:inline">AS AT 30 JUNE 2019<div style="display:none"><ix:nonNumeric contextRef="B" format="ixt:datelonguk" name="bus:BalanceSheetDate">30 June 2019</ix:nonNumeric></div></div></div><div class="clb fn2" style="top:90.64pt;left:46.61pt;width:423.77pt;"></div><div class="cln fn0 sln" style="top:100.56pt;left:46.61pt;width:420.77pt;"></div><div class="cln fn0 sln" style="top:695.49pt;left:46.61pt;width:420.77pt;"></div><div class="ccn fn7" style="top:701.96pt;left:46.61pt;width:420.77pt;">- 3 -</div><div class="cjn fn2" style="top:114.16pt;left:46.61pt;width:419.51pt;">The financial statements were approved by the board of directors and authorised for issue on <ix:nonNumeric contextRef="B" format="ixt:datelonguk" name="core:DateAuthorisationFinancialStatementsForIssue">27 March 2020</ix:nonNumeric> and are signed on its behalf by:</div><div class="clb fn2" style="top:168.98pt;left:46.61pt;width:196.27pt;"><ix:nonNumeric contextRef="C_MV_NQ" name="core:DirectorSigningFinancialStatements"></ix:nonNumeric>Dr M V Van Bussel</div><div class="clb fn2" style="top:168.98pt;left:239.88pt;width:229.24pt;"><ix:nonNumeric contextRef="C_MV_NR" name="core:DirectorSigningFinancialStatements"></ix:nonNumeric>Dr M R Arif</div><div class="clb fn2" style="top:180.2pt;left:46.61pt;width:196.27pt;">Director</div><div class="clb fn2" style="top:180.2pt;left:239.88pt;width:229.24pt;">Director</div><div class="clb fn2" style="top:225.08pt;left:46.61pt;width:196.27pt;">Dr D Goh</div><div class="clb fn2" style="top:225.08pt;left:239.88pt;width:229.24pt;">Dr R Vedapanakal</div><div class="clb fn2" style="top:236.31pt;left:46.61pt;width:196.27pt;">Director</div><div class="clb fn2" style="top:236.31pt;left:239.88pt;width:229.24pt;">Director</div><div class="cln fn8" style="top:236.31pt;left:466.77pt;width:0.65pt;"></div><div class="clb fn2" style="top:258.75pt;left:46.61pt;width:422.51pt;">Company Registration No. 06625215</div></div><div class="portraitPage" style="height:727pt;width:516pt;"><div class="clb fn2" style="top:31.08pt;left:46.61pt;width:423.77pt;"></div><div class="clb fn5" style="top:41pt;left:46.61pt;width:423.77pt;"><ix:nonNumeric contextRef="C" name="bus:EntityCurrentLegalOrRegisteredName">FELLVIEW HEALTHCARE LTD</ix:nonNumeric></div><div class="clb fn5" style="top:52.91pt;left:46.61pt;width:423.77pt;"></div><div class="clb fn2" style="top:64.83pt;left:46.61pt;width:423.77pt;">NOTES TO THE FINANCIAL STATEMENTS </div><div class="cln fn6" style="top:74.75pt;left:46.61pt;width:420.77pt;"></div><div class="clb fn2" style="top:80.71pt;left:46.61pt;width:423.77pt;">FOR THE YEAR ENDED 30 JUNE 2019</div><div class="clb fn2" style="top:90.64pt;left:46.61pt;width:423.77pt;"></div><div class="cln fn0 sln" style="top:100.56pt;left:46.61pt;width:420.77pt;"></div><div class="cln fn0 sln" style="top:695.49pt;left:46.61pt;width:420.77pt;"></div><div class="ccn fn7" style="top:701.96pt;left:46.61pt;width:420.77pt;">- 4 -</div><div class="clb fn2" style="top:114.16pt;left:46.61pt;width:24.12pt;">1</div><div class="clb fn2" style="top:114.16pt;left:67.73pt;width:401.41pt;">Accounting policies</div><div class="cln fn8" style="top:114.16pt;left:466.79pt;width:0.65pt;"></div><div class="clb fn2" style="top:136.61pt;left:67.73pt;width:401.41pt;">Company information</div><div class="cln" style="top:148pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn2">Fellview Healthcare Ltd is a</span><span class="fn2"> private </span><span class="fn2">company</span><span class="fn2"> limited by shares</span><span class="fn2"> incorporated in England and Wales.</span><span class="fn2"> </span><span class="fn2">The registered office is</span><span class="fn2"> Flatt Walks Health Centre, 3 Castle Meadows, Whitehaven, CA28 7QE.</span></p></div><div class="clb fn2" style="top:180.2pt;left:46.61pt;width:24.12pt;">1.1</div><div class="clb fn2" style="top:180.2pt;left:67.73pt;width:401.41pt;">Accounting convention</div><div class="cln" style="top:191pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="core:StatementComplianceWithApplicableReportingFramework"><span class="fn2">These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.</span></ix:nonNumeric></p></div><div class="cln" style="top:253pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn2">The financial statements are prepared in</span><span class="fn2"> sterling</span><span class="fn2">, which is the functional currency of the company. </span><span class="fn2">Monetary a</span><span class="fn2">mounts </span><span class="fn2">in these financial statements are </span><span class="fn2">rounded to the nearest £.</span></p></div><div class="cln" style="top:285pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="core:GeneralDescriptionBasisMeasurementUsedInPreparingFinancialStatements"><span class="fn2">The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.</span></ix:nonNumeric></p></div><div class="clb fn2" style="top:317.02pt;left:46.61pt;width:24.12pt;">1.2</div><div class="clb fn2" style="top:317.02pt;left:67.73pt;width:401.41pt;">Going concern</div><div class="cln" style="top:328pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="core:FinancialStatementsArePreparedOnGoing-concernBasisTruefalse" continuedAt="C_NZ_0"><span class="fn2"><ix:exclude>T</ix:exclude><span style="display:none">true</span></span></ix:nonNumeric><span class="fn2"></span><ix:continuation id="C_NZ_0" continuedAt="C_NZ_1"><span class="fn2"><ix:exclude>he company will cease trading </ix:exclude></span></ix:continuation><span class="fn2"></span><ix:continuation id="C_NZ_1" continuedAt="C_NZ_2"><span class="fn2"><ix:exclude>when the NHS contract expires </ix:exclude></span></ix:continuation><span class="fn2"></span><ix:continuation id="C_NZ_2" continuedAt="C_NZ_3"><span class="fn2"><ix:exclude>on 3</ix:exclude></span></ix:continuation><span class="fn2"></span><ix:continuation id="C_NZ_3" continuedAt="C_NZ_4"><span class="fn2"><ix:exclude>0</ix:exclude></span></ix:continuation><span class="fn2"> </span><ix:continuation id="C_NZ_4" continuedAt="C_NZ_5"><span class="fn2"><ix:exclude>September</ix:exclude></span></ix:continuation><span class="fn2"></span><ix:continuation id="C_NZ_5" continuedAt="C_NZ_6"><span class="fn2"><ix:exclude> 2019</ix:exclude></span></ix:continuation><span class="fn2"></span><ix:continuation id="C_NZ_6" continuedAt="C_NZ_7"><span class="fn2"><ix:exclude>.</ix:exclude></span></ix:continuation><span class="fn2"> </span><ix:continuation id="C_NZ_7" continuedAt="C_NZ_8"><span class="fn2"><ix:exclude>As required by UK accounting standards, the directors have prepared the financial statements on the basis that the company is no longer a going concern. No material adjustments arose as a result of ceasing to apply the going concern basis. T</ix:exclude></span></ix:continuation><span class="fn2"></span><ix:continuation id="C_NZ_8" continuedAt="C_NZ_9"><span class="fn2"><ix:exclude>he company’s assets </ix:exclude></span></ix:continuation><span class="fn2"></span><ix:continuation id="C_NZ_9" continuedAt="C_NZ_10"><span class="fn2"><ix:exclude>have still been valued at their net book values</ix:exclude></span></ix:continuation><span class="fn2"></span><ix:continuation id="C_NZ_10"><span class="fn2"><ix:exclude>. No provision has been made for the future costs of terminating the business unless such costs were committed at the reporting date.</ix:exclude></span></ix:continuation></p></div><div class="clb fn2" style="top:399.89pt;left:46.61pt;width:24.12pt;">1.3</div><div class="clb fn2" style="top:399.89pt;left:67.73pt;width:401.41pt;">Turnover</div><div class="cln" style="top:411pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="core:RevenueRecognitionPolicy" continuedAt="C_OA_0"><span class="fn2">The income and expenditure account is prepared on an accruals basic so as to reflect actual income earned and expenditure incurred during the year.</span></ix:nonNumeric></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn2">&#160;</span></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:continuation id="C_OA_0"><span class="fn2">The financial statements are prepared taking into account principles outlined in the Alternative Provider Medical Services reports and budgets.</span></ix:continuation></p></div><div class="clb fn2" style="top:495.28pt;left:46.61pt;width:24.12pt;">1.4</div><div class="clb fn2" style="top:495.28pt;left:67.73pt;width:401.41pt;">Tangible fixed assets</div><div class="cln" style="top:506pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="core:DescriptionMeasurementBasisForPropertyPlantEquipment" continuedAt="C_OB_0"><span class="fn2">Tangible fixed assets </span></ix:nonNumeric><span class="fn2"></span><ix:continuation id="C_OB_0"><span class="fn2">are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.</span></ix:continuation></p></div><div class="cln" style="top:538pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Justify;"><ix:nonNumeric contextRef="C" name="core:DescriptionDepreciationMethodForPropertyPlantEquipment"><span class="fn2">Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:</span></ix:nonNumeric></p></div><div class="cln fn2" style="top:570.38pt;left:67.73pt;width:172.16pt;">Leasehold Land and buildings</div><div class="cln fn2" style="top:570.38pt;left:239.9pt;width:227.49pt;"><ix:nonNumeric contextRef="C_LI_MX_LJ_MY" name="core:DescriptionDepreciationMethodForPropertyPlantEquipment">Straight line over 25 years</ix:nonNumeric></div><div class="cln fn2" style="top:581.6pt;left:67.73pt;width:172.16pt;">Medical equipment</div><div class="cln fn2" style="top:581.6pt;left:239.9pt;width:227.49pt;"><ix:nonNumeric contextRef="C_LI_MZ" name="core:DescriptionDepreciationMethodForPropertyPlantEquipment">20% reducing balance</ix:nonNumeric></div><div class="cln fn2" style="top:592.82pt;left:67.73pt;width:172.16pt;">Office equipment</div><div class="cln fn2" style="top:592.82pt;left:239.9pt;width:227.49pt;"><ix:nonNumeric contextRef="C_LI_NA" name="core:DescriptionDepreciationMethodForPropertyPlantEquipment">20% reducing balance</ix:nonNumeric></div><div class="cln fn2" style="top:604.05pt;left:67.73pt;width:172.16pt;">Prior practices fixed assets</div><div class="cln fn2" style="top:604.05pt;left:239.9pt;width:227.49pt;"><ix:nonNumeric contextRef="C_LI_NB" name="core:DescriptionDepreciationMethodForPropertyPlantEquipment">20% reducing balance</ix:nonNumeric></div><div class="cln" style="top:626pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn2">The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and </span><span class="fn2">is credited or charged to profit or loss</span><span class="fn2">.</span></p></div></div><div class="portraitPage" style="height:727pt;width:516pt;"><div class="clb fn2" style="top:31.08pt;left:46.61pt;width:423.77pt;"></div><div class="clb fn5" style="top:41pt;left:46.61pt;width:423.77pt;"><ix:nonNumeric contextRef="C" name="bus:EntityCurrentLegalOrRegisteredName">FELLVIEW HEALTHCARE LTD</ix:nonNumeric></div><div class="clb fn5" style="top:52.91pt;left:46.61pt;width:423.77pt;"></div><div class="clb fn2" style="top:64.83pt;left:46.61pt;width:423.77pt;">NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)</div><div class="cln fn6" style="top:74.75pt;left:46.61pt;width:420.77pt;"></div><div class="clb fn2" style="top:80.71pt;left:46.61pt;width:423.77pt;">FOR THE YEAR ENDED 30 JUNE 2019</div><div class="clb fn2" style="top:90.64pt;left:46.61pt;width:423.77pt;"></div><div class="cln fn0 sln" style="top:100.56pt;left:46.61pt;width:420.77pt;"></div><div class="clb fn2" style="top:113.51pt;left:46.61pt;width:24.12pt;">1</div><div class="clb fn2" style="top:113.51pt;left:67.73pt;width:401.41pt;">Accounting policies</div><div class="crb fn2" style="top:113.51pt;left:378.06pt;width:89.32pt;">(Continued)</div><div class="cln fn0 sln" style="top:695.49pt;left:46.61pt;width:420.77pt;"></div><div class="ccn fn7" style="top:701.96pt;left:46.61pt;width:420.77pt;">- 5 -</div><div class="clb fn2" style="top:136.39pt;left:46.61pt;width:24.12pt;">1.5</div><div class="clb fn2" style="top:136.39pt;left:67.73pt;width:401.41pt;">Impairment of fixed assets</div><div class="cln" style="top:147pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="core:ImpairmentNon-financialAssetsPolicy" continuedAt="C_OC_0"><span class="fn2">At each reporting </span></ix:nonNumeric><span class="fn2"></span><ix:continuation id="C_OC_0" continuedAt="C_OC_1"><span class="fn2">period </span></ix:continuation><span class="fn2"></span><ix:continuation id="C_OC_1" continuedAt="C_OC_2"><span class="fn2">end date, the </span></ix:continuation><span class="fn2"></span><ix:continuation id="C_OC_2" continuedAt="C_OC_3"><span class="fn2">company </span></ix:continuation><span class="fn2"></span><ix:continuation id="C_OC_3" continuedAt="C_OC_4"><span class="fn2">reviews the carrying amounts of its tangible</span></ix:continuation><span class="fn2"></span><ix:continuation id="C_OC_4" continuedAt="C_OC_5"><span class="fn2"> assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company </span></ix:continuation><span class="fn2"></span><ix:continuation id="C_OC_5" continuedAt="C_OC_6"><span class="fn2">estimates the recoverable amount of the cash-generating unit to which the asset belongs.</span></ix:continuation></p></div><div class="cln" style="top:219pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:continuation id="C_OC_6" continuedAt="C_OC_7"><span class="fn2">Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.</span></ix:continuation></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn2">&#160;</span></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:continuation id="C_OC_7" continuedAt="C_OC_8"><span class="fn2">If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.</span></ix:continuation></p></div><div class="cln" style="top:320pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:continuation id="C_OC_8" continuedAt="C_OC_9"><span class="fn2">Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) </span></ix:continuation><span class="fn2"></span><ix:continuation id="C_OC_9" continuedAt="C_OC_10"><span class="fn2">in </span></ix:continuation><span class="fn2"></span><ix:continuation id="C_OC_10"><span class="fn2">prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.</span></ix:continuation></p></div><div class="clb fn2" style="top:402.27pt;left:46.61pt;width:24.12pt;">1.6</div><div class="clb fn2" style="top:402.27pt;left:67.73pt;width:401.41pt;">Stocks</div><div class="cln" style="top:413pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="core:InventoriesPolicy" continuedAt="C_OD_0"><span class="fn2">Stocks are estimated at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.</span></ix:nonNumeric></p></div><div class="cln" style="top:445pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:continuation id="C_OD_0"><span class="fn2">At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.</span></ix:continuation></p></div><div class="clb fn2" style="top:487.29pt;left:46.61pt;width:24.12pt;">1.7</div><div class="clb fn2" style="top:487.29pt;left:67.73pt;width:401.41pt;">Cash at bank and in hand</div><div class="cln" style="top:498pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="core:CashCashEquivalentsPolicy" continuedAt="C_OE_0"><span class="fn2">Cash at bank and in hand </span></ix:nonNumeric><span class="fn2"></span><ix:continuation id="C_OE_0" continuedAt="C_OE_1"><span class="fn2">are basic financial assets</span></ix:continuation><span class="fn2"></span><ix:continuation id="C_OE_1" continuedAt="C_OE_2"><span class="fn2"> and</span></ix:continuation><span class="fn2"></span><ix:continuation id="C_OE_2"><span class="fn2"> include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.</span></ix:continuation></p></div><div class="clb fn2" style="top:540.38pt;left:46.61pt;width:24.12pt;">1.8</div><div class="clb fn2" style="top:540.38pt;left:67.73pt;width:401.41pt;">Financial instruments</div><div class="cln" style="top:551pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="core:FinancialInstrumentsClassificationPolicy" continuedAt="C_OF_0"><span class="fn2">The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments. </span></ix:nonNumeric></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn2">&#160;</span></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:continuation id="C_OF_0" continuedAt="C_OF_1"><span class="fn2">Financial instruments are recognised in the company&apos;s balance sheet when the company becomes party to the contractual provisions of the instrument.</span></ix:continuation></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn2">&#160;</span></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:continuation id="C_OF_1" continuedAt="C_OF_2"><span class="fn2">Financial assets and liabilities are offset</span></ix:continuation><span class="fn2"></span><ix:continuation id="C_OF_2" continuedAt="C_OF_3"><span class="fn2">, with</span></ix:continuation><span class="fn2"></span><ix:continuation id="C_OF_3" continuedAt="C_OF_4"><span class="fn2"> the net amounts presented in the financial statements</span></ix:continuation><span class="fn2"></span><ix:continuation id="C_OF_4" continuedAt="C_OF_5"><span class="fn2">,</span></ix:continuation><span class="fn2"></span><ix:continuation id="C_OF_5"><span class="fn2"> when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.</span></ix:continuation></p></div></div><div class="portraitPage" style="height:727pt;width:516pt;"><div class="clb fn2" style="top:31.08pt;left:46.61pt;width:423.77pt;"></div><div class="clb fn5" style="top:41pt;left:46.61pt;width:423.77pt;"><ix:nonNumeric contextRef="C" name="bus:EntityCurrentLegalOrRegisteredName">FELLVIEW HEALTHCARE LTD</ix:nonNumeric></div><div class="clb fn5" style="top:52.91pt;left:46.61pt;width:423.77pt;"></div><div class="clb fn2" style="top:64.83pt;left:46.61pt;width:423.77pt;">NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)</div><div class="cln fn6" style="top:74.75pt;left:46.61pt;width:420.77pt;"></div><div class="clb fn2" style="top:80.71pt;left:46.61pt;width:423.77pt;">FOR THE YEAR ENDED 30 JUNE 2019</div><div class="clb fn2" style="top:90.64pt;left:46.61pt;width:423.77pt;"></div><div class="cln fn0 sln" style="top:100.56pt;left:46.61pt;width:420.77pt;"></div><div class="clb fn2" style="top:113.51pt;left:46.61pt;width:24.12pt;">1</div><div class="clb fn2" style="top:113.51pt;left:67.73pt;width:401.41pt;">Accounting policies</div><div class="crb fn2" style="top:113.51pt;left:378.06pt;width:89.32pt;">(Continued)</div><div class="cln fn0 sln" style="top:695.49pt;left:46.61pt;width:420.77pt;"></div><div class="ccn fn7" style="top:701.96pt;left:46.61pt;width:420.77pt;">- 6 -</div><div class="clbi fn2" style="top:136.17pt;left:67.73pt;width:344.85pt;">Basic financial assets</div><div class="cln" style="top:147pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn2">Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest</span><span class="fn2"> </span><span class="fn2">method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.</span><span class="fn2"> Financial assets classified as receivable within one year are not amortised.</span></p></div><div class="clbi fn2" style="top:208.69pt;left:67.73pt;width:401.41pt;">Classification of financial liabilities</div><div class="cln" style="top:219pt;left:68pt;width:398pt;text-align:left;font-family:Arial;font-size:8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn2">Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.</span></p></div><div class="clbi fn2" style="top:261.34pt;left:67.73pt;width:401.41pt;">Basic financial liabilities</div><div class="cln" style="top:272pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn2">Basic financial liabilities, including creditors, bank loans, loans from</span><span class="fn2"> </span><span class="fn2">fellow group companies and preference shares that are classified as debt, are</span><span class="fn2"> </span><span class="fn2">initially recognised at transaction price unless the arrangement constitutes a</span><span class="fn2"> </span><span class="fn2">financing transaction, where the debt instrument is measured at the present value of</span><span class="fn2"> </span><span class="fn2">the future </span><span class="fn2">paymen</span><span class="fn2">ts discounted at a market rate of interest.</span><span class="fn2"> Financial liabilities classified as payable within one year are not amortised.</span></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn2">&#160;</span></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn2">Debt instruments are subsequently carried at amortised cost, using the effective</span><span class="fn2"> </span><span class="fn2">interest rate method.</span></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn2">&#160;</span></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn2">Trade creditors</span><span class="fn2"> are obligations to pay for goods or services that have been acquired</span><span class="fn2"> </span><span class="fn2">in the ordinary course of business from suppliers. A</span><span class="fn2">m</span><span class="fn2">ounts payable are classified as</span><span class="fn2"> </span><span class="fn2">current liabilities if payment is due within one year or less. If not, they are presented</span><span class="fn2"> </span><span class="fn2">as non-current liabilities. Trade creditors are recognised initially at transaction price</span><span class="fn2"> </span><span class="fn2">and subsequently measured at amortised cost using the effective interest method.</span></p></div><div class="clb fn2" style="top:435.93pt;left:46.61pt;width:24.12pt;">1.9</div><div class="clb fn2" style="top:435.93pt;left:67.73pt;width:401.41pt;">Taxation</div><div class="cln" style="top:447pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Justify;"><ix:nonNumeric contextRef="C" name="core:TaxPolicy"><span class="fn2">The tax expense represents the sum of the tax currently payable and deferred tax.</span></ix:nonNumeric></p></div><div class="clbi fn2" style="top:468.95pt;left:67.73pt;width:401.41pt;">Current tax</div><div class="cln" style="top:480pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="core:CurrentIncomeTaxPolicy" continuedAt="C_OG_0"><span class="fn2">The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The </span></ix:nonNumeric><span class="fn2"></span><ix:continuation id="C_OG_0" continuedAt="C_OG_1"><span class="fn2">company’s </span></ix:continuation><span class="fn2"></span><ix:continuation id="C_OG_1"><span class="fn2">liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.</span></ix:continuation></p></div></div><div class="portraitPage" style="height:727pt;width:516pt;"><div class="clb fn2" style="top:31.08pt;left:46.61pt;width:423.77pt;"></div><div class="clb fn5" style="top:41pt;left:46.61pt;width:423.77pt;"><ix:nonNumeric contextRef="C" name="bus:EntityCurrentLegalOrRegisteredName">FELLVIEW HEALTHCARE LTD</ix:nonNumeric></div><div class="clb fn5" style="top:52.91pt;left:46.61pt;width:423.77pt;"></div><div class="clb fn2" style="top:64.83pt;left:46.61pt;width:423.77pt;">NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)</div><div class="cln fn6" style="top:74.75pt;left:46.61pt;width:420.77pt;"></div><div class="clb fn2" style="top:80.71pt;left:46.61pt;width:423.77pt;">FOR THE YEAR ENDED 30 JUNE 2019</div><div class="clb fn2" style="top:90.64pt;left:46.61pt;width:423.77pt;"></div><div class="cln fn0 sln" style="top:100.56pt;left:46.61pt;width:420.77pt;"></div><div class="clb fn2" style="top:113.51pt;left:46.61pt;width:24.12pt;">1</div><div class="clb fn2" style="top:113.51pt;left:67.73pt;width:401.41pt;">Accounting policies</div><div class="crb fn2" style="top:113.51pt;left:378.06pt;width:89.32pt;">(Continued)</div><div class="cln fn0 sln" style="top:695.49pt;left:46.61pt;width:420.77pt;"></div><div class="ccn fn7" style="top:701.96pt;left:46.61pt;width:420.77pt;">- 7 -</div><div class="clbi fn2" style="top:136.17pt;left:67.73pt;width:401.41pt;">Deferred tax</div><div class="cln" style="top:147pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="core:DeferredTaxPolicy" continuedAt="C_OH_0"><span class="fn2">Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.</span></ix:nonNumeric></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn2">&#160;</span></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:continuation id="C_OH_0" continuedAt="C_OH_1"><span class="fn2">The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the </span></ix:continuation><span class="fn2"></span><ix:continuation id="C_OH_1" continuedAt="C_OH_2"><span class="fn2">company </span></ix:continuation><span class="fn2"></span><ix:continuation id="C_OH_2"><span class="fn2">has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.</span></ix:continuation></p></div><div class="clb fn2" style="top:298.24pt;left:46.61pt;width:24.12pt;">1.10</div><div class="clb fn2" style="top:298.24pt;left:67.73pt;width:401.41pt;">Employee benefits</div><div class="cln" style="top:309pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="core:EmployeeBenefitsPolicy" continuedAt="C_OI_0"><span class="fn2">The costs of short-term employee benefits are recognised as a liability and an expense</span></ix:nonNumeric><span class="fn2"></span><ix:continuation id="C_OI_0" continuedAt="C_OI_1"><span class="fn2">.</span></ix:continuation></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn2">&#160;</span></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:continuation id="C_OI_1" continuedAt="C_OI_2"><span class="fn2">The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.</span></ix:continuation></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn2">&#160;</span></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:continuation id="C_OI_2"><span class="fn2">Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.</span></ix:continuation></p></div><div class="clb fn2" style="top:391.05pt;left:46.61pt;width:24.12pt;">1.11</div><div class="clb fn2" style="top:391.05pt;left:67.73pt;width:401.41pt;">Retirement benefits</div><div class="cln" style="top:402pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="core:DefinedContributionPensionsPolicy"><span class="fn2">The company operates a defined benefit pension scheme for its director and employees. The contributions are paid to the NHS Pension scheme which is a defined benefit pension scheme. This scheme is a public sector scheme and contributions are accounted for as they fall due.</span></ix:nonNumeric></p></div><div class="clb fn2" style="top:444.14pt;left:46.61pt;width:24.12pt;">1.12</div><div class="clb fn2" style="top:444.14pt;left:67.73pt;width:401.41pt;">Leases</div><div class="cln" style="top:455pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Justify;"><ix:nonNumeric contextRef="C" name="core:LessorOperatingLeasePolicy"><span class="fn2">Rental income from operating leases is recognised on a straight line basis over the term of the relevant lease. Initial direct costs incurred in negotiating and arranging an operating lease are added to the carrying amount of the leased asset and recognised on a straight line basis over the lease term.</span></ix:nonNumeric></p></div><div class="clb fn2" style="top:497.22pt;left:46.61pt;width:24.12pt;">2</div><div class="clb fn2" style="top:497.22pt;left:67.73pt;width:402.65pt;">Employees</div><div class="cln" style="top:520pt;left:68pt;width:400pt;text-align:justify;font-family:Arial;font-size:8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn2">The average monthly number of persons (including directors) employed by the company during the year was 99 (2018 - 97).</span></p></div></div><div class="portraitPage" style="height:727pt;width:516pt;"><div class="clb fn2" style="top:31.08pt;left:46.61pt;width:423.77pt;"></div><div class="clb fn5" style="top:41pt;left:46.61pt;width:423.77pt;"><ix:nonNumeric contextRef="C" name="bus:EntityCurrentLegalOrRegisteredName">FELLVIEW HEALTHCARE LTD</ix:nonNumeric></div><div class="clb fn5" style="top:52.91pt;left:46.61pt;width:423.77pt;"></div><div class="clb fn2" style="top:64.83pt;left:46.61pt;width:423.77pt;">NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)</div><div class="cln fn6" style="top:74.75pt;left:46.61pt;width:420.77pt;"></div><div class="clb fn2" style="top:80.71pt;left:46.61pt;width:423.77pt;">FOR THE YEAR ENDED 30 JUNE 2019</div><div class="clb fn2" style="top:90.64pt;left:46.61pt;width:423.77pt;"></div><div class="cln fn0 sln" style="top:100.56pt;left:46.61pt;width:420.77pt;"></div><div class="cln fn0 sln" style="top:695.49pt;left:46.61pt;width:420.77pt;"></div><div class="ccn fn7" style="top:701.96pt;left:46.61pt;width:420.77pt;">- 8 -</div><div class="clb fn2" style="top:114.16pt;left:46.61pt;width:24.12pt;">3</div><div class="clb fn2" style="top:114.16pt;left:67.73pt;width:394.55pt;">Tangible fixed assets</div><div class="crb fn2" style="top:125.38pt;left:307.13pt;width:52.72pt;">Leasehold Land and buildings</div><div class="crb fn2" style="top:125.38pt;left:356.85pt;width:52.72pt;">Plant and machinery etc</div><div class="crb fn2" style="top:125.38pt;left:406.58pt;width:60.81pt;">Total</div><div class="crb fn2" style="top:156.46pt;left:307.13pt;width:52.72pt;">£</div><div class="crb fn2" style="top:156.46pt;left:356.85pt;width:52.72pt;">£</div><div class="crb fn2" style="top:156.46pt;left:406.58pt;width:60.81pt;">£</div><div class="cln fn8" style="top:156.46pt;left:468.03pt;width:0.65pt;"></div><div class="clb fn2" style="top:167.68pt;left:67.73pt;width:394.55pt;">Cost</div><div class="cln fn2" style="top:178.9pt;left:67.73pt;width:242.4pt;">At 1 July 2018</div><div class="crn fn2" style="top:178.9pt;left:310.13pt;width:49.72pt;"><ix:nonFraction contextRef="A_LI_MX" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:PropertyPlantEquipmentGrossCost">46,180</ix:nonFraction></div><div class="crn fn2" style="top:178.9pt;left:359.85pt;width:49.72pt;"><ix:nonFraction contextRef="A_LI_NC" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:PropertyPlantEquipmentGrossCost">119,683</ix:nonFraction></div><div class="crn fn2" style="top:178.9pt;left:409.58pt;width:57.81pt;"><ix:nonFraction contextRef="A" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:PropertyPlantEquipmentGrossCost">165,863</ix:nonFraction></div><div class="cln fn2" style="top:190.12pt;left:67.73pt;width:242.4pt;">Additions</div><div class="crn fn2" style="top:190.12pt;left:310.13pt;width:49.72pt;">-</div><div class="crn fn2" style="top:190.12pt;left:359.85pt;width:49.72pt;"><ix:nonFraction contextRef="C_LI_NC" decimals="0" scale="0" unitRef="GBP" name="core:TotalAdditionsIncludingFromBusinessCombinationsPropertyPlantEquipment">494</ix:nonFraction></div><div class="crn fn2" style="top:190.12pt;left:409.58pt;width:57.81pt;"><ix:nonFraction contextRef="C" decimals="0" scale="0" unitRef="GBP" name="core:TotalAdditionsIncludingFromBusinessCombinationsPropertyPlantEquipment">494</ix:nonFraction></div><div class="cln fn0 sln" style="top:206.31pt;left:328.65pt;width:31.19pt;"></div><div class="cln fn0 sln" style="top:206.31pt;left:378.38pt;width:31.19pt;"></div><div class="cln fn0 sln" style="top:206.31pt;left:436.19pt;width:31.19pt;"></div><div class="cln fn2" style="top:212.57pt;left:67.73pt;width:242.4pt;">At 30 June 2019</div><div class="crn fn2" style="top:212.57pt;left:310.13pt;width:49.72pt;"><ix:nonFraction contextRef="B_LI_MX" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:PropertyPlantEquipmentGrossCost">46,180</ix:nonFraction></div><div class="crn fn2" style="top:212.57pt;left:359.85pt;width:49.72pt;"><ix:nonFraction contextRef="B_LI_NC" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:PropertyPlantEquipmentGrossCost">120,177</ix:nonFraction></div><div class="crn fn2" style="top:212.57pt;left:409.58pt;width:57.81pt;"><ix:nonFraction contextRef="B" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:PropertyPlantEquipmentGrossCost">166,357</ix:nonFraction></div><div class="cln fn0 sln" style="top:228.76pt;left:328.65pt;width:31.19pt;"></div><div class="cln fn0 sln" style="top:228.76pt;left:378.38pt;width:31.19pt;"></div><div class="cln fn0 sln" style="top:228.76pt;left:436.19pt;width:31.19pt;"></div><div class="clb fn2" style="top:235.36pt;left:67.73pt;width:245.4pt;">Depreciation and impairment</div><div class="crn fn9" style="top:235.36pt;left:310.13pt;width:49.72pt;"></div><div class="cln fn2" style="top:246.93pt;left:67.73pt;width:242.4pt;">At 1 July 2018</div><div class="crn fn2" style="top:246.93pt;left:310.13pt;width:49.72pt;"><ix:nonFraction contextRef="A_LI_MX" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:AccumulatedDepreciationImpairmentPropertyPlantEquipment">9,444</ix:nonFraction></div><div class="crn fn2" style="top:246.93pt;left:359.85pt;width:49.72pt;"><ix:nonFraction contextRef="A_LI_NC" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:AccumulatedDepreciationImpairmentPropertyPlantEquipment">75,976</ix:nonFraction></div><div class="crn fn2" style="top:246.93pt;left:409.58pt;width:57.81pt;"><ix:nonFraction contextRef="A" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:AccumulatedDepreciationImpairmentPropertyPlantEquipment">85,420</ix:nonFraction></div><div class="cln fn2" style="top:258.15pt;left:67.73pt;width:242.4pt;">Depreciation charged in the year</div><div class="crn fn2" style="top:258.15pt;left:310.13pt;width:49.72pt;"><ix:nonFraction contextRef="C_LI_MX" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:IncreaseFromDepreciationChargeForYearPropertyPlantEquipment">36,736</ix:nonFraction></div><div class="crn fn2" style="top:258.15pt;left:359.85pt;width:49.72pt;"><ix:nonFraction contextRef="C_LI_NC" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:IncreaseFromDepreciationChargeForYearPropertyPlantEquipment">8,840</ix:nonFraction></div><div class="crn fn2" style="top:258.15pt;left:409.58pt;width:57.81pt;"><ix:nonFraction contextRef="C" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:IncreaseFromDepreciationChargeForYearPropertyPlantEquipment">45,576</ix:nonFraction></div><div class="cln fn0 sln" style="top:274.33pt;left:328.65pt;width:31.19pt;"></div><div class="cln fn0 sln" style="top:274.33pt;left:378.38pt;width:31.19pt;"></div><div class="cln fn0 sln" style="top:274.33pt;left:436.19pt;width:31.19pt;"></div><div class="cln fn2" style="top:280.6pt;left:67.73pt;width:242.4pt;">At 30 June 2019</div><div class="crn fn2" style="top:280.6pt;left:310.13pt;width:49.72pt;"><ix:nonFraction contextRef="B_LI_MX" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:AccumulatedDepreciationImpairmentPropertyPlantEquipment">46,180</ix:nonFraction></div><div class="crn fn2" style="top:280.6pt;left:359.85pt;width:49.72pt;"><ix:nonFraction contextRef="B_LI_NC" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:AccumulatedDepreciationImpairmentPropertyPlantEquipment">84,816</ix:nonFraction></div><div class="crn fn2" style="top:280.6pt;left:409.58pt;width:57.81pt;"><ix:nonFraction contextRef="B" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:AccumulatedDepreciationImpairmentPropertyPlantEquipment">130,996</ix:nonFraction></div><div class="cln fn0 sln" style="top:296.78pt;left:328.65pt;width:31.19pt;"></div><div class="cln fn0 sln" style="top:296.78pt;left:378.38pt;width:31.19pt;"></div><div class="cln fn0 sln" style="top:296.78pt;left:436.19pt;width:31.19pt;"></div><div class="clb fn2" style="top:303.04pt;left:67.73pt;width:394.55pt;">Carrying amount</div><div class="cln fn2" style="top:314.26pt;left:67.73pt;width:242.4pt;">At 30 June 2019</div><div class="crn fn2" style="top:314.26pt;left:310.13pt;width:49.72pt;">-</div><div class="crn fn2" style="top:314.26pt;left:359.85pt;width:49.72pt;"><ix:nonFraction contextRef="B_LI_NC" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:PropertyPlantEquipment">35,361</ix:nonFraction></div><div class="crn fn2" style="top:314.26pt;left:409.58pt;width:57.81pt;"><ix:nonFraction contextRef="B" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:PropertyPlantEquipment">35,361</ix:nonFraction></div><div class="cln fn0 dln" style="top:330.45pt;left:328.65pt;width:31.19pt;"></div><div class="cln fn0 dln" style="top:330.45pt;left:378.38pt;width:31.19pt;"></div><div class="cln fn0 dln" style="top:330.45pt;left:436.19pt;width:31.19pt;"></div><div class="cln fn2" style="top:336.71pt;left:67.73pt;width:242.4pt;">At 30 June 2018</div><div class="crn fn2" style="top:336.71pt;left:310.13pt;width:49.72pt;"><ix:nonFraction contextRef="E_LI_MX" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:PropertyPlantEquipment">36,736</ix:nonFraction></div><div class="crn fn2" style="top:336.71pt;left:359.85pt;width:49.72pt;"><ix:nonFraction contextRef="E_LI_NC" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:PropertyPlantEquipment">43,706</ix:nonFraction></div><div class="crn fn2" style="top:336.71pt;left:409.58pt;width:57.81pt;"><ix:nonFraction contextRef="E" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:PropertyPlantEquipment">80,442</ix:nonFraction></div><div class="cln fn0 dln" style="top:352.89pt;left:328.65pt;width:31.19pt;"></div><div class="cln fn0 dln" style="top:352.89pt;left:378.38pt;width:31.19pt;"></div><div class="cln fn0 dln" style="top:352.89pt;left:436.19pt;width:31.19pt;"></div><div class="clb fn2" style="top:370.37pt;left:46.61pt;width:24.12pt;">4</div><div class="clb fn2" style="top:370.37pt;left:67.73pt;width:231.1pt;">Debtors</div><div class="crb fn2" style="top:381.59pt;left:349.39pt;width:59.56pt;">2019</div><div class="crb fn2" style="top:381.59pt;left:405.95pt;width:61.43pt;">2018</div><div class="clb fn2" style="top:392.81pt;left:67.73pt;width:174.54pt;">Amounts falling due within one year:</div><div class="crb fn2" style="top:392.81pt;left:349.39pt;width:59.56pt;">£</div><div class="crb fn2" style="top:392.81pt;left:405.95pt;width:61.43pt;">£</div><div class="cln fn8" style="top:392.81pt;left:468.03pt;width:0.65pt;"></div><div class="cln fn2" style="top:415.26pt;left:67.73pt;width:171.54pt;">Trade debtors</div><div class="crn fn2" style="top:415.26pt;left:352.39pt;width:56.56pt;"><ix:nonFraction contextRef="B_LR_MQ" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:TradeDebtorsTradeReceivables">207,585</ix:nonFraction></div><div class="crn fn2" style="top:415.26pt;left:408.95pt;width:58.43pt;"><ix:nonFraction contextRef="E_LR_MQ" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:TradeDebtorsTradeReceivables">270,374</ix:nonFraction></div><div class="cln fn2" style="top:426.48pt;left:67.73pt;width:171.54pt;">Other debtors</div><div class="crn fn2" style="top:426.48pt;left:352.39pt;width:56.56pt;"><ix:nonFraction contextRef="B_LV_ND" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:OtherDebtors">3,242</ix:nonFraction></div><div class="crn fn2" style="top:426.48pt;left:408.95pt;width:58.43pt;"><ix:nonFraction contextRef="E_LV_ND" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:OtherDebtors">44,651</ix:nonFraction></div><div class="cln fn0 sln" style="top:442.67pt;left:377.76pt;width:31.19pt;"></div><div class="cln fn0 sln" style="top:442.67pt;left:436.19pt;width:31.19pt;"></div><div class="crn fn2" style="top:448.93pt;left:352.39pt;width:56.56pt;"><ix:nonFraction contextRef="B_LR_MQ_LV_ND" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:Debtors">210,827</ix:nonFraction></div><div class="crn fn2" style="top:448.93pt;left:408.95pt;width:58.43pt;"><ix:nonFraction contextRef="E_LR_MQ_LV_ND" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:Debtors">315,025</ix:nonFraction></div><div class="cln fn0 dln" style="top:465.11pt;left:377.76pt;width:31.19pt;"></div><div class="cln fn0 dln" style="top:465.11pt;left:436.19pt;width:31.19pt;"></div><div class="clb fn2" style="top:493.81pt;left:46.61pt;width:24.12pt;">5</div><div class="clb fn2" style="top:493.81pt;left:67.73pt;width:287.66pt;">Creditors: amounts falling due within one year</div><div class="crb fn2" style="top:505.04pt;left:349.39pt;width:59.56pt;">2019</div><div class="crb fn2" style="top:505.04pt;left:405.95pt;width:61.43pt;">2018</div><div class="crb fn2" style="top:516.26pt;left:349.39pt;width:59.56pt;">£</div><div class="crb fn2" style="top:516.26pt;left:405.95pt;width:61.43pt;">£</div><div class="cln fn8" style="top:516.26pt;left:468.03pt;width:0.65pt;"></div><div class="cln fn2" style="top:538.71pt;left:67.73pt;width:228.1pt;">Corporation tax</div><div class="crn fn2" style="top:538.71pt;left:352.39pt;width:56.56pt;"><ix:nonFraction contextRef="B" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:CorporationTaxPayable">180,377</ix:nonFraction></div><div class="crn fn2" style="top:538.71pt;left:408.95pt;width:58.43pt;"><ix:nonFraction contextRef="E" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:CorporationTaxPayable">177,112</ix:nonFraction></div><div class="cln fn2" style="top:549.93pt;left:67.73pt;width:228.1pt;">Other creditors</div><div class="crn fn2" style="top:549.93pt;left:352.39pt;width:56.56pt;"><ix:nonFraction contextRef="B_LR_MQ" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:OtherCreditors">152,155</ix:nonFraction></div><div class="crn fn2" style="top:549.93pt;left:408.95pt;width:58.43pt;"><ix:nonFraction contextRef="E_LR_MQ" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:OtherCreditors">147,803</ix:nonFraction></div><div class="cln fn0 sln" style="top:566.11pt;left:377.76pt;width:31.19pt;"></div><div class="cln fn0 sln" style="top:566.11pt;left:436.19pt;width:31.19pt;"></div><div class="crn fn2" style="top:572.37pt;left:352.39pt;width:56.56pt;"><ix:nonFraction contextRef="B_LR_MQ" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:Creditors">332,532</ix:nonFraction></div><div class="crn fn2" style="top:572.37pt;left:408.95pt;width:58.43pt;"><ix:nonFraction contextRef="E_LR_MQ" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:Creditors">324,915</ix:nonFraction></div><div class="cln fn0 dln" style="top:588.56pt;left:377.76pt;width:31.19pt;"></div><div class="cln fn0 dln" style="top:588.56pt;left:436.19pt;width:31.19pt;"></div><div class="clb fn2" style="top:606.04pt;left:46.61pt;width:24.12pt;">6</div><div class="clb fn2" style="top:606.04pt;left:67.73pt;width:231.1pt;">Creditors: amounts falling due after more than one year</div><div class="crb fn2" style="top:627.18pt;left:349.39pt;width:59.56pt;">2019</div><div class="crb fn2" style="top:627.18pt;left:405.95pt;width:61.43pt;">2018</div><div class="crb fn2" style="top:638.41pt;left:349.39pt;width:59.56pt;">£</div><div class="crb fn2" style="top:638.41pt;left:405.95pt;width:61.43pt;">£</div><div class="cln fn8" style="top:638.41pt;left:468.03pt;width:0.65pt;"></div><div class="cln fn2" style="top:660.85pt;left:67.73pt;width:228.1pt;">Other creditors</div><div class="crn fn2" style="top:660.85pt;left:352.39pt;width:56.56pt;">-</div><div class="crn fn2" style="top:660.85pt;left:408.95pt;width:58.43pt;"><ix:nonFraction contextRef="E_LR_MR" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:OtherCreditors">50,000</ix:nonFraction></div><div class="cln fn0 dln" style="top:677.03pt;left:377.76pt;width:31.19pt;"></div><div class="cln fn0 dln" style="top:677.03pt;left:436.19pt;width:31.19pt;"></div></div><div class="portraitPage" style="height:727pt;width:516pt;"><div class="clb fn2" style="top:31.08pt;left:46.61pt;width:423.77pt;"></div><div class="clb fn5" style="top:41pt;left:46.61pt;width:423.77pt;"><ix:nonNumeric contextRef="C" name="bus:EntityCurrentLegalOrRegisteredName">FELLVIEW HEALTHCARE LTD</ix:nonNumeric></div><div class="clb fn5" style="top:52.91pt;left:46.61pt;width:423.77pt;"></div><div class="clb fn2" style="top:64.83pt;left:46.61pt;width:423.77pt;">NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)</div><div class="cln fn6" style="top:74.75pt;left:46.61pt;width:420.77pt;"></div><div class="clb fn2" style="top:80.71pt;left:46.61pt;width:423.77pt;">FOR THE YEAR ENDED 30 JUNE 2019</div><div class="clb fn2" style="top:90.64pt;left:46.61pt;width:423.77pt;"></div><div class="cln fn0 sln" style="top:100.56pt;left:46.61pt;width:420.77pt;"></div><div class="cln fn0 sln" style="top:695.49pt;left:46.61pt;width:420.77pt;"></div><div class="ccn fn7" style="top:701.96pt;left:46.61pt;width:420.77pt;">- 9 -</div><div class="clb fn2" style="top:114.16pt;left:46.61pt;width:24.12pt;">7</div><div class="clb fn2" style="top:114.16pt;left:67.73pt;width:287.66pt;">Called up share capital</div><div class="crb fn2" style="top:125.38pt;left:349.39pt;width:59.56pt;">2019</div><div class="crb fn2" style="top:125.38pt;left:405.95pt;width:61.43pt;">2018</div><div class="crb fn2" style="top:136.61pt;left:349.39pt;width:59.56pt;">£</div><div class="crb fn2" style="top:136.61pt;left:405.95pt;width:61.43pt;">£</div><div class="cln fn8" style="top:136.61pt;left:468.03pt;width:0.65pt;"></div><div class="clb fn2" style="top:147.83pt;left:67.73pt;width:287.66pt;">Ordinary share capital</div><div class="clb fn2" style="top:159.05pt;left:67.73pt;width:400.78pt;">Issued and fully paid</div><div class="cln fn2" style="top:170.27pt;left:67.73pt;width:228.1pt;">4 Ordinary C to T shares of £1 each</div><div class="crn fn2" style="top:170.27pt;left:352.39pt;width:56.56pt;">4</div><div class="crn fn2" style="top:170.27pt;left:408.95pt;width:58.43pt;">4</div><div class="cln fn0 dln" style="top:186.46pt;left:377.76pt;width:31.19pt;"></div><div class="cln fn0 dln" style="top:186.46pt;left:436.19pt;width:31.19pt;"></div><div class="clb fn2" style="top:203.94pt;left:46.61pt;width:24.12pt;">8</div><div class="clb fn2" style="top:203.94pt;left:67.73pt;width:400.78pt;">Operating lease commitments</div><div class="cln fn8" style="top:203.94pt;left:466.16pt;width:0.65pt;"></div><div class="clb fn2" style="top:226.38pt;left:67.73pt;width:400.78pt;">Lessee</div><div class="cln" style="top:237pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn2">At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows:</span></p></div><div class="crb fn2" style="top:258.32pt;left:349.39pt;width:59.56pt;">2019</div><div class="crb fn2" style="top:258.32pt;left:405.95pt;width:61.43pt;">2018</div><div class="crb fn2" style="top:269.54pt;left:349.39pt;width:59.56pt;">£</div><div class="crb fn2" style="top:269.54pt;left:405.95pt;width:61.43pt;">£</div><div class="cln fn8" style="top:269.54pt;left:468.03pt;width:0.65pt;"></div><div class="crn fn2" style="top:291.99pt;left:352.39pt;width:56.56pt;"><ix:nonFraction contextRef="B" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:FutureMinimumLeasePaymentsUnderNon-cancellableOperatingLeases">96,927</ix:nonFraction></div><div class="crn fn2" style="top:291.99pt;left:408.95pt;width:58.43pt;"><ix:nonFraction contextRef="E" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:FutureMinimumLeasePaymentsUnderNon-cancellableOperatingLeases">381,267</ix:nonFraction></div><div class="cln fn0 dln" style="top:308.18pt;left:377.76pt;width:31.19pt;"></div><div class="cln fn0 dln" style="top:308.18pt;left:436.19pt;width:31.19pt;"></div><div class="cln" style="top:325pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn2">The reimbursable commitments relate to rental payments for property occupied for the delivery of a specific service contract. These rental payments are fully reimbursable by the commissioners for the duration of the contract.</span></p></div></div><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="B" name="bus:EndDateForPeriodCoveredByReport">2019-06-30</ix:nonNumeric><ix:nonNumeric contextRef="B" name="bus:StartDateForPeriodCoveredByReport">2018-07-01</ix:nonNumeric><ix:nonNumeric contextRef="C" name="bus:EntityDormantTruefalse">false</ix:nonNumeric><ix:nonNumeric contextRef="C" name="bus:EntityTradingStatus"></ix:nonNumeric><ix:nonNumeric contextRef="B" format="ixt:datelonguk" name="aurep:DateAuditorsReport">31 March 2020</ix:nonNumeric><ix:nonNumeric contextRef="C_NH_NI" name="bus:LegalFormEntity"></ix:nonNumeric><ix:nonNumeric contextRef="C" name="bus:NameProductionSoftware">CCH Software</ix:nonNumeric><ix:nonNumeric contextRef="C_NJ_NK" name="bus:ApplicableLegislation"></ix:nonNumeric><ix:nonNumeric contextRef="C" name="bus:VersionProductionSoftware">CCH Accounts Production 2019.200</ix:nonNumeric><ix:nonNumeric contextRef="C_NL_NM" name="bus:AccountingStandardsApplied"></ix:nonNumeric><ix:nonNumeric contextRef="C_NN_NO" name="bus:AccountsStatusAuditedOrUnaudited"></ix:nonNumeric><ix:nonNumeric contextRef="C" name="bus:DescriptionPrincipalActivities">No description of principal activity</ix:nonNumeric><ix:nonNumeric contextRef="C" name="bus:ScopeAccounts"></ix:nonNumeric><ix:nonNumeric contextRef="C_MV_NQ" name="bus:NameEntityOfficer">Dr M V Van Bussel</ix:nonNumeric><ix:nonNumeric contextRef="C_MV_NR" name="bus:NameEntityOfficer">Dr M R Arif</ix:nonNumeric><ix:nonNumeric contextRef="C_MV_NS" name="bus:NameEntityOfficer">Dr D Goh</ix:nonNumeric><ix:nonNumeric contextRef="C_MV_NT" name="bus:NameEntityOfficer">Dr R Vedapanakal</ix:nonNumeric><ix:nonNumeric contextRef="C_MV_NU" name="bus:NameEntityOfficer">Mr M&#160;&#160;Megan</ix:nonNumeric><ix:nonNumeric contextRef="C_NV_NW" name="bus:AccountsTypeFullOrAbbreviated"></ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="https://xbrl.frc.org.uk/FRS-102/2019-01-01/FRS-102-2019-01-01.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="C"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">06625215</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="B"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">06625215</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="E"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">06625215</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="B_LI_NC"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">06625215</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:PropertyPlantEquipmentClassesDimension">core:OtherPropertyPlantEquipment</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="E_LI_MX"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">06625215</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:PropertyPlantEquipmentClassesDimension">core:LandBuildings</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="E_LI_NC"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">06625215</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:PropertyPlantEquipmentClassesDimension">core:OtherPropertyPlantEquipment</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="B_LR_MQ_LV_ND"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">06625215</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:FinancialInstrumentCurrentNon-currentDimension">core:CurrentFinancialInstruments</xbrldi:explicitMember><xbrldi:explicitMember dimension="core:MaturitiesOrExpirationPeriodsDimension">core:WithinOneYear</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="E_LR_MQ_LV_ND"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">06625215</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:FinancialInstrumentCurrentNon-currentDimension">core:CurrentFinancialInstruments</xbrldi:explicitMember><xbrldi:explicitMember dimension="core:MaturitiesOrExpirationPeriodsDimension">core:WithinOneYear</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="B_LR_MQ"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">06625215</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:FinancialInstrumentCurrentNon-currentDimension">core:CurrentFinancialInstruments</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="E_LR_MQ"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">06625215</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:FinancialInstrumentCurrentNon-currentDimension">core:CurrentFinancialInstruments</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="E_LR_MR"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">06625215</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:FinancialInstrumentCurrentNon-currentDimension">core:Non-currentFinancialInstruments</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="B_MS_MT"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">06625215</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:EquityClassesDimension">core:ShareCapital</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="E_MS_MT"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">06625215</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:EquityClassesDimension">core:ShareCapital</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="B_MS_MU"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">06625215</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:EquityClassesDimension">core:RetainedEarningsAccumulatedLosses</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="E_MS_MU"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">06625215</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:EquityClassesDimension">core:RetainedEarningsAccumulatedLosses</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_MV_NQ"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">06625215</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bus:EntityOfficersDimension">bus:Director1</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_MV_NR"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">06625215</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bus:EntityOfficersDimension">bus:Director2</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_LI_MX_LJ_MY"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">06625215</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:PropertyPlantEquipmentClassesDimension">core:LandBuildings</xbrldi:explicitMember><xbrldi:explicitMember dimension="core:PPEOwnershipDimension">core:LeasedAssetsHeldAsLessee</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_LI_MZ"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">06625215</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:PropertyPlantEquipmentClassesDimension">core:PlantMachinery</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_LI_NA"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">06625215</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:PropertyPlantEquipmentClassesDimension">core:FurnitureFittings</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_LI_NB"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">06625215</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:PropertyPlantEquipmentClassesDimension">core:MotorVehicles</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="A_LI_MX"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">06625215</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:PropertyPlantEquipmentClassesDimension">core:LandBuildings</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="A_LI_NC"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">06625215</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:PropertyPlantEquipmentClassesDimension">core:OtherPropertyPlantEquipment</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="A"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">06625215</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="B_LI_MX"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">06625215</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:PropertyPlantEquipmentClassesDimension">core:LandBuildings</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_LI_NC"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">06625215</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:PropertyPlantEquipmentClassesDimension">core:OtherPropertyPlantEquipment</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_LI_MX"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">06625215</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:PropertyPlantEquipmentClassesDimension">core:LandBuildings</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="B_LV_ND"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">06625215</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:MaturitiesOrExpirationPeriodsDimension">core:WithinOneYear</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="E_LV_ND"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">06625215</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:MaturitiesOrExpirationPeriodsDimension">core:WithinOneYear</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_NH_NI"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">06625215</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bus:LegalFormEntityDimension">bus:PrivateLimitedCompanyLtd</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_NJ_NK"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">06625215</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bus:ApplicableLegislationDimension">bus:SmallCompaniesRegimeForAccounts</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_NL_NM"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">06625215</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bus:AccountingStandardsDimension">bus:FRS102</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_NN_NO"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">06625215</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bus:AccountsStatusDimension">bus:AuditExemptWithAccountantsReport</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_MV_NS"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">06625215</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bus:EntityOfficersDimension">bus:Director3</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_MV_NT"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">06625215</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bus:EntityOfficersDimension">bus:Director4</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_MV_NU"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">06625215</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bus:EntityOfficersDimension">bus:CompanySecretary1</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_NV_NW"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">06625215</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bus:AccountsTypeDimension">bus:FullAccounts</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="Pure"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="Shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="GBP"><xbrli:measure>iso4217:GBP</xbrli:measure></xbrli:unit></ix:resources></ix:header></div></body></html>